Loading company…
MasterMediTech uses protein structure and medicinal chemistry methods for drug discovery.
Founded in 2019 and based in Seoul, MasterMediTech develops drugs using chemical technology, protein structure, and medicinal chemistry. CEO Bongjin LEE led the company as of 2023. In March 2021, it raised KRW 8 billion in Series A funding from CP Partners, Huons Medicare, Samho Green Investment, and Spring Camp.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in